Assistant Professor, Medicine, Vanderbilt University School of Medicine
Oncology
Dr. Ingrid Mayer, MD
|
|
Give Review
Doctor Ingrid Mayer, MD is an expert in the field of Oncology. He researched medicine at University of Illinois College of Medicine at Chicago. University of Illinois College of Medicine at Chicago has a rank of 49 in research and a 85 in primary care He over the years received 5 awards: "Regional Top Doctor", "Meaningful Use Stage 1 Certification", "Five Star Awards in the Excellence in Healthcare Awards", "Alpha Omega Alpha Honor Medical Society (AOA)" and "Department of Medicine House Staff Award, PGY-II of the Year". Ingrid Mayer is also a published doctor. He has 36 publication published. The most recent publication is: Phase I/II study of pilaralisib (SAR245408) in combination with trastuzumab or trastuzumab plus paclitaxel in trastuzumab-refractory HER2-positive metastatic breast ca... He accepts all Medicare patients.
Publications
- Kinome-wide functional screen identifies role of PLK1 in hormone-independent, ER-positive breast cancer.
- Phase I/II study of pilaralisib (SAR245408) in combination with trastuzumab or trastuzumab plus paclitaxel in trastuzumab-refractory HER2-positive metastatic breast ca...
- Enabling a Genetically Informed Approach to Cancer Medicine: A Retrospective Evaluation of the Impact of Comprehensive Tumor Profiling Using a Targeted Next-Generation...
- Characterization of breast cancers with PI3K mutations in an academic practice setting using SNaPshot profiling.
- Stand up to cancer phase ib study of pan-phosphoinositide-3-kinase inhibitor buparlisib with letrozole in estrogen receptor-positive/human epidermal growth factor rece...
- New strategies for triple-negative breast cancer--deciphering the heterogeneity.
- Subtyping of triple-negative breast cancer.
- Breast Cancer, Version 3.2013.
- Thrombotic microangiopathy during docetaxel, trastuzumab, and carboplatin chemotherapy for early-stage HER2+ breast cancer: a case report.
- DCE-MRI analysis methods for predicting the response of breast cancer to neoadjuvant chemotherapy: Pilot study findings.
- Role of mTOR Inhibition in Preventing Resistance and Restoring Sensitivity to Hormone-Targeted and HER2-Targeted Therapies in Breast Cancer.
- Time course of arthralgia among women initiating aromatase inhibitor therapy and a postmenopausal comparison group in a prospective cohort.
- Circulating neuregulin during the transition from stage A to stage B/C heart failure in a breast cancer cohort.
- An algorithm for longitudinal registration of PET/CT images acquired during neoadjuvant chemotherapy in breast cancer: preliminary results.
- Targeting cytokine receptors and pathways in the treatment of breast cancer.
- Neoadjuvant concurrent paclitaxel and radiation in stage II/III breast cancer.
- Integration of quantitative DCE-MRI and ADC mapping to monitor treatment response in human breast cancer: initial results.
- Short preoperative treatment with erlotinib inhibits tumor cell proliferation in hormone receptor-positive breast cancers.
- Evaluation of biological agents targeted at early-stage disease.
- Breast cancer. Clinical practice guidelines in oncology.
- Treatment of HER2-positive metastatic breast cancer following initial progression.
- Identification of markers of taxane sensitivity using proteomic and genomic analyses of breast tumors from patients receiving neoadjuvant paclitaxel and radiation.
- Does lapatinib work against HER2-negative breast cancers?
- Antiangiogenic therapies in early-stage breast cancer.
- Breast cancer: noninvasive and special situations.
- Evaluation of metformin in early breast cancer: a modification of the traditional paradigm for clinical testing of anti-cancer agents.
- Invasive breast cancer.
- Motion correction in diffusion-weighted MRI of the breast at 3T.
- A novel AIF tracking method and comparison of DCE-MRI parameters using individual and population-based AIFs in human breast cancer.
- Clinical utility of serum tumor markers and circulating tumor cell assays in the treatment of breast cancer.
- Temporal sampling requirements for reference region modeling of DCE-MRI data in human breast cancer.
- A nonrigid registration algorithm for longitudinal breast MR images and the analysis of breast tumor response.
- Validation of an algorithm for the nonrigid registration of longitudinal breast MR images using realistic phantoms.
- Hydro-MRI in Crohn's disease: appraisal of disease activity.
- [Assessment of inflammatory activity in Crohn disease with hydro-MRI].
Schools
University of Sao Paulo Faculty of Medicine
University Of Illinois
Procedures Preformed
- Cardiac MRI (Magnetic Resonance Imaging) of Heart or Chest
- Plasmapheresis
Doctors Specialties
- Hematology
- Medical Oncology
- Oncology
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- American Republic
- Amerigroup (Wellpoint)
- Assurant Health
- Blue Card PPO
- Network S
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- LocalPlus
- Open Access Plus
- Commercial Insurance Company
- Coventry Health Care of Tennessee PPO
- GEHA
- Choice Care PPO
- Medicare MCR
- Medico
- PHCS Network PPO
- POMCO Group
- Tricare
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- United Healthcare
Awards
- Regional Top Doctor
- Meaningful Use Stage 1 Certification
- Five Star Awards in the Excellence in Healthcare Awards
- Alpha Omega Alpha Honor Medical Society (AOA)
- Department of Medicine House Staff Award, PGY-II of the Year
Education
-
Vanderbilt University School of Medicine -
University of Illinois College of Medicine at Chicago
Hospital
-
Vanderbilt Hospital and Clinics
Drug Facts
| NPI NUMBER | 1871677971 | |
| NPPES Provider LastName | MAYER | |
| NPPES Provider FirstName | INGRID | |
| NPPES Provider ZIPCode | 372320001 | |
| NPPES Provider State | TN | |
| Specialty Description | Hematology/Oncology | |
| Total Claim Count | 580.0 | |
| Distinct Opioid Count | 3.0 | |
| Opioid Claim Count | 46.0 | |
| Percent Opioid Claims | 7.93 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1871677971 |
| Last Name Of The Provider | MAYER |
| First Name Of The Provider | INGRID |
| View All |
Similar Doctors
|
|
Dr. Adetola A. Kassim, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. William C. Penley, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Bipin N. Savani, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
Dr. Jordan D. Berlin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kristin K. Ancell, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. William Pao, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Terence T. Casey, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Christina L. Derleth, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Philip E. Lammers, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Salyka M. Sengsayadeth, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Kenneth R. Hande, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
Dr. Alicia K. Morgans, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Carl R. Willis, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mace L. Rothenberg, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Valerie M. Jansen, MD |
|
Dr. Vicki L. Keedy, MD
This Doctor is OpenDoctor Recommended.
|